US 9518091
A4B7 peptide monomer and dimer antagonists
granted A61KA61K38/00A61P
Quick answer
US patent 9518091 (A4B7 peptide monomer and dimer antagonists) held by Protagonist Therapeutics, Inc. expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Protagonist Therapeutics, Inc.
- Grant date
- Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K38/00, A61P, A61P1/00, A61P1/04